FLGT – Fulgent Genetics, Inc.

Fulgent Genetics, Inc.

FLGT

$25.70

Name : Fulgent Genetics, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $718,032,320.00

EPSttm : -3.1

Fulgent Genetics, Inc.

$25.70

0.31%

$0.08

FLGT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

11.93

Margin Of Safety %

Put/Call OI Ratio

0.02

EPS Next Q Diff

-0.12

EPS Last/This Y

-2.69

EPS This/Next Y

0.89

Price

25.75

Target Price

Analyst Recom

Performance Q

37.79

Upside

-519.5%

Beta

0.99

Ticker: FLGT

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	FLGT	21.47	0.13	0.00	3256
2026-10-13	FLGT	21.08	0.13	1.00	3258
2026-10-14	FLGT	20.95	0.13	0.53	3257
2026-10-15	FLGT	21.29	0.13	0.00	3254
2026-10-16	FLGT	19.86	0.12	0.98	3267
2026-10-19	FLGT	20.11	0.04	0.01	1778
2026-10-20	FLGT	20.3	0.03	0.04	2056
2026-10-21	FLGT	20.11	0.03	0.00	2106
2026-10-22	FLGT	19.96	0.03	0.00	2130
2026-10-23	FLGT	20.07	0.03	0.00	2128
2026-10-26	FLGT	20.21	0.03	999.99	2181
2026-10-27	FLGT	20.65	0.03	0.00	2181
2026-10-28	FLGT	21.47	0.03	0.33	2188
2026-10-29	FLGT	21.69	0.03	0.00	2196
2026-10-30	FLGT	20.58	0.03	0.00	2207
2026-11-02	FLGT	19.29	0.03	0.01	2210
2026-11-03	FLGT	19.35	0.03	0.00	2267
2026-11-04	FLGT	19.68	0.03	0.00	2267
2026-11-05	FLGT	18.58	0.02	0.01	3194
2026-11-06	FLGT	23.78	0.02	0.05	3309
2026-11-09	FLGT	26.17	0.03	0.01	3424
2026-11-10	FLGT	25.74	0.02	0.07	4594
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	FLGT	21.47	-100.0	-	-2.27
2026-10-13	FLGT	21.09	-100.0	-	-2.27
2026-10-14	FLGT	20.99	-100.0	-	-2.27
2026-10-15	FLGT	21.33	-100.0	-	-2.27
2026-10-16	FLGT	19.83	-100.0	-	-2.27
2026-10-19	FLGT	20.11	-100.0	-	-2.27
2026-10-20	FLGT	20.11	-100.0	-	-2.27
2026-10-21	FLGT	20.31	-100.0	-	-2.27
2026-10-22	FLGT	19.98	-100.0	-	-2.27
2026-10-23	FLGT	20.10	-100.0	-	-2.27
2026-10-26	FLGT	20.22	-100.0	-	-2.27
2026-10-27	FLGT	20.69	-100.0	-	-2.27
2026-10-28	FLGT	21.52	-100.0	-	-2.27
2026-10-29	FLGT	21.67	-100.0	-	-2.27
2026-10-30	FLGT	20.54	-100.0	-	-2.27
2026-11-02	FLGT	19.30	-100.0	-	-2.27
2026-11-03	FLGT	19.33	-100.0	-	-2.27
2026-11-04	FLGT	19.67	-100.0	-	-2.27
2026-11-05	FLGT	18.58	-100.0	-	-2.27
2026-11-06	FLGT	23.79	-100.0	-	-2.27
2026-11-09	FLGT	26.14	-100.0	-	-2.27
2026-11-10	FLGT	25.75	-100.0	-	-2.27
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	FLGT	-0.12	-10.32	12.71
2026-10-13	FLGT	-0.12	-10.32	12.71
2026-10-14	FLGT	-0.12	-10.32	12.71
2026-10-15	FLGT	-0.12	-10.32	12.71
2026-10-16	FLGT	-0.12	-10.32	12.71
2026-10-19	FLGT	-0.12	-10.72	12.71
2026-10-20	FLGT	-0.12	-10.72	12.71
2026-10-21	FLGT	-0.12	-10.72	12.71
2026-10-22	FLGT	-0.12	-10.72	12.71
2026-10-23	FLGT	-0.12	-10.72	12.71
2026-10-26	FLGT	-0.12	-10.89	12.71
2026-10-27	FLGT	-0.12	-10.89	12.11
2026-10-28	FLGT	-0.12	-10.89	12.11
2026-10-29	FLGT	-0.12	-10.89	12.11
2026-10-30	FLGT	-0.12	-10.89	12.11
2026-11-02	FLGT	-0.12	-10.90	12.11
2026-11-03	FLGT	-0.12	-10.90	12.11
2026-11-05	FLGT	-0.12	-10.90	12.11
2026-11-06	FLGT	-0.12	-10.90	12.11
2026-11-09	FLGT	-0.12	-10.74	11.93
2026-11-10	FLGT	-0.12	-10.74	11.93
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.38

Avg. EPS Est. Current Quarter

-0.69

Avg. EPS Est. Next Quarter

-0.5

Insider Transactions

-0.12

Institutional Transactions

-10.74

Beta

0.99

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

76.5

Max Drawdown 5-Year %

-86.9

Target Price

P/E

Forward P/E

PEG

P/S

2.18

P/B

0.72

P/Free Cash Flow

EPS

-3.09

Average EPS Est. Cur. Y

-2.27

EPS Next Y. (Est.)

-1.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-27.53

Relative Volume

Return on Equity vs Sector %

-35.5

Return on Equity vs Industry %

-20.9

EPS 1 7Days Diff

-0.7

EPS 1 30Days Diff

-0.72

EBIT Estimation

◆ FLGT Healthcare

$25.78

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

4/25

Volume

0/15

Valuation

3/20

TP/AR

2/10

Options

7/10

RSI

68.8

Range 1M

85.6%

Sup Dist

6.5%

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

22/25

Growth

9/30

Estimates

3/20

Inst/Vol

6/15

Options

10/10

EPS Yr

-504.8%

EPS NY

20%

52W%

71.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -3% upside

Quality

5/30

Valuation

2/30

Growth

11/25

Stability

6/10

LT Trend

4/5

Upside

-3%

Quality

FLGT — P/E HistoricalDiagnostics & Research

Fulgent Genetics, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 1315

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, large corporations, and patients. Fulgent Genetics, Inc. was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.

FLGT

Latest News

—

Caricamento notizie per FLGT…

stock quote shares FLGT – Fulgent Genetics, Inc. Stock Price stock today

news today FLGT – Fulgent Genetics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch FLGT – Fulgent Genetics, Inc. yahoo finance google finance

stock history FLGT – Fulgent Genetics, Inc. invest stock market

stock prices FLGT premarket after hours

ticker FLGT fair value insiders trading

FLGT – Fulgent Genetics, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: FLGT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y